Effect of carnosine or beta-alanine supplementation therapy for prediabetes or type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
Li N, Yan X, Lin J, Wu M, et al.
Published in BMC Endocrine Disorders
Abstract
Systematic review and meta-analysis of randomized trials of carnosine or beta-alanine in prediabetes and type 2 diabetes.
Key Findings
Carnosine supplementation significantly lowered HbA1c and improved insulin resistance versus placebo in prediabetes and type 2 diabetes, while effects on fasting insulin were not significant.
Conclusions
Carnosine shows modest glycemic benefit in dysglycemia, but trial numbers remain small.
Limitations
Small number of eligible RCTs; short durations; heterogeneity in dose.
Supplements Studied
Carnosine supplementation significantly lowered HbA1c and improved insulin resistance versus placebo in prediabetes and type 2 diabetes, while effects on fasting insulin were not significant.
Carnosine supplementation significantly lowered HbA1c and improved insulin resistance versus placebo in prediabetes and type 2 diabetes, while effects on fasting insulin were not significant.
Outcomes Measured
Carnosine supplementation significantly lowered HbA1c and improved insulin resistance versus placebo in prediabetes and type 2 diabetes, while effects on fasting insulin were not significant.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.